![]() |
市场调查报告书
商品编码
1494827
可穿戴机器人和外骨骼的全球市场:分析 - 按类型、按身体部位、按技术、按应用、按最终用户、按地区和预测(截至 2030 年)Wearable Robots and Exoskeletons Market Forecasts to 2030 - Global Analysis By Type (Passive Exoskeletons, Powered Exoskeletons and Other Types), Body Part (Lower Body, Full Body and Upper Body), Technology, Application, End User and By Geography |
预计2024年全球穿戴式机器人和外骨骼市场规模将达17.9亿美元,预测期内复合年增长率为44.4%,到2030年将达到162.3亿美元。
穿戴式机器人/外骨骼是旨在提高人类表现的机械设备。提供身体支持和帮助,尤其是在需要力量和耐力的任务中。透过增加佩戴者的肌肉力量和耐力,这些设备可应用于医疗保健、军事和工业等各个领域。它们可以帮助受伤或手术后的康復,帮助工人轻鬆举起重物,并提高士兵在战场上的表现。
根据 Maxon Motor AG 的研究,估计全球约有 1.85 亿人每天使用轮椅。帕金森氏症基金会估计,到2020年,美国帕金森氏症患者人数可能达到约93万人,预计2030年将达到120万人。
残障人士数量增加和人口老化
残障人士数量的增加和人口老化是穿戴式机器人和外骨骼市场的重要驱动因素。随着人口老化,对增强流动性和协助日常活动的解决方案的需求日益增长。穿戴式机器人/外骨骼恰好满足了这一需求,支持有运动障碍或老龄化相关限制的个体的独立性并提高其生活品质。这些技巧可以帮助执行原本难以执行的任务,例如行走、举重和长时间站立。
高成本
穿戴式机器人和外骨骼市场的高成本限制是普及的重大经济障碍。製造这些设备需要复杂的工程和先进的技术,导致生产成本高。此外,製造业有限的规模经济导致价格更高。因此,获得这些创新技术主要仅限于财力雄厚的产业或富人。这种成本限制阻碍了大众市场渗透的潜力,并限制了这些设备在医疗保健、製造和国防等各个领域所能提供的好处。
不断增加的医疗保健和復健需求
对医疗保健和復健服务的需求不断增长正在推动穿戴式机器人和外骨骼市场的成长。这些创新技术为身体残疾和受伤的人提供了更多的活动能力和支持,从而提高了他们的独立性和生活品质。随着人口老化的增加和慢性病发病率的增加,对支持日常活动和復原过程的解决方案的需求日益增长。穿戴式机器人外骨骼透过为每个用户的特定需求提供可自订的支援来满足这一需求,它们在全球医疗保健机构和復健中心的采用正在迅速增加。
有限的知识和指导
穿戴式机器人和外骨骼市场中有限的知识和指导威胁是指对这些先进设备的正确使用和维护的理解和指导不足所带来的风险。用户可能不完全了解其功能和限制,这可能会导致误用和事故。培训和教育资源不足可能会进一步加剧这种风险,导致人身伤害和设备损坏。应对这项威胁需要全面的用户教育计画和製造商的明确说明。
穿戴式机器人/外骨骼市场受到了 COVID-19 的多方面影响。儘管疫情引起了人们对这些设备在医疗保健环境中的价值的关注,但全球供应链和製造业务的中断导致生产和交货延迟。由于疫情造成的经济不确定性,工业和军事应用的可穿戴机器人和外骨骼的需求也有所下降。然而,远端医疗和远端患者监护的日益普及预计将增加医疗保健行业对穿戴式机器人和外骨骼的需求,从而创造巨大的市场机会。
预计在预测期内工业部门将是最大的
由于穿戴式机器人/外骨骼在製造、物流和建筑领域的使用不断增加,预计在预测期内,工业领域将占据穿戴式机器人/外骨骼的最大市场占有率。穿戴式机器人和外骨骼被用来提高工业工作的生产力和效率,同时减少工人的疲劳和受伤风险。由于製造业对自动化和机器人技术的需求不断增加,预计市场将继续扩大。随着公司寻求提高工人的生产力和安全性,可穿戴机器人和外骨骼预计将在物流和建筑领域变得普及流行。
復健产业预计在预测期内复合年增长率最高
预计康復产业在预测期内将出现最快的复合年增长率。復健领域是市场上成长最快的领域。这是由于残障人士数量不断增加,以及对加速疾病和受伤復健的医疗设备的需求不断增加。由于穿戴式机器人和外骨骼的出现,復健市场正在扩大。预计这一趋势未来仍将持续。
预计在预测期内,北美将占据全球穿戴式机器人和外骨骼市场的最大份额。这是由于对能够改善患者治疗结果和工人安全的设备的需求不断增加,而医疗保健和工业部门是北美成长的主要驱动力。此外,北美市场的成长也受到该领域重要製造商的存在和技术进步的推动。
在亚太地区,由于工业和医疗保健领域越来越多地使用这些设备,预计可穿戴机器人和外骨骼市场的复合年增长率最高。随着人口持续老化和残障人士比例较高,亚太地区市场预计将扩大。廉价劳动力的可用性和政府鼓励采用最尖端科技的支持措施预计也将刺激该地区的市场扩张。
According to Stratistics MRC, the Global Wearable Robots And Exoskeletons Market is accounted for $1.79 billion in 2024 and is expected to reach $16.23 billion by 2030 growing at a CAGR of 44.4% during the forecast period. Wearable robots and exoskeletons are mechanical devices designed to enhance human capabilities. They provide physical support and assistance, particularly in tasks requiring strength or endurance. By augmenting the wearer's strength and endurance, these devices find applications in various fields, including healthcare, military, and industry. They can aid in rehabilitation after injury or surgery, enable workers to lift heavy objects with ease, and enhance soldiers' performance on the battlefield.
According to a study by Maxon Motor AG, the company estimated that approximately 185 million people use a wheelchair daily worldwide. According to the Parkinson's Foundation estimates, the number of people in the United States with Parkinson's disease may be around 930,000 in 2020, and it is expected to reach 1,200,000 by 2030.
Increasing prevalence of disabilities and an aging population
The increasing prevalence of disabilities and an aging population are significant drivers in the wearable robots and exoskeletons market. As populations age, there's a growing need for solutions that enhance mobility and provide assistance in daily activities. Wearable robots and exoskeletons offer precisely that, aiding individuals with mobility impairments or age-related limitations to maintain independence and improve quality of life. These technologies enable users to perform tasks they might otherwise struggle with, such as walking, lifting, or standing for extended periods of time.
High cost
High cost restraint in the wearable robots and exoskeletons market is the significant financial barrier hindering widespread adoption. The intricate engineering and advanced technology involved in creating these devices contribute to their high production costs. Additionally, limited economies of scale in manufacturing further inflate prices. As a result, accessibility to these transformative technologies is restricted, primarily to well-funded industries or affluent individuals. This cost constraint impedes the potential for mass-market penetration and limits the benefits these devices could offer in various fields, including healthcare, manufacturing, and defense.
Increase in the need for healthcare and rehabilitation
The rise in demand for healthcare and rehabilitation services has propelled the growth of the wearable robots and exoskeletons market. These innovative technologies offer enhanced mobility and support for individuals with physical impairments or injuries, thereby increasing their independence and quality of life. As the aging population grows and the incidence of chronic conditions rises, there's a heightened need for solutions that can assist in daily activities and rehabilitation processes. Wearable robots and exoskeletons cater to this demand by providing customizable support tailored to each user's specific needs, leading to a surge in their adoption across healthcare facilities and rehabilitation centers globally. This
Limited knowledge and instruction
The threat of limited knowledge and instruction in the wearable robots and exoskeletons market refers to the risk posed by inadequate understanding or guidance regarding the proper usage and maintenance of these advanced devices. Users may not fully comprehend their capabilities or limitations, leading to misuse or accidents. Insufficient training and educational resources further exacerbate this risk, potentially resulting in injuries or damage to the equipment. Addressing this threat requires comprehensive user education programs and clear instructions provided by manufacturers.
The Wearable robot and exoskeleton Market has been impacted by COVID-19 in a variety of ways. Even though the pandemic has brought attention to the value of these devices in healthcare settings, delays in production and delivery have resulted from the disruption of global supply chains and manufacturing operations. The demand for wearable robots and exoskeletons in industrial and military applications has also decreased as a result of the economic uncertainty brought on by the pandemic. However, it is anticipated that the growing use of telemedicine and remote patient monitoring will fuel demand for wearable robots and exoskeletons in the healthcare industry, creating a sizable opportunity for the market.
The industrial segment is expected to be the largest during the forecast period
The industrial sector will hold the largest market share for wearable robots and exoskeletons during the forecast period as a result of the growing use of these tools in the manufacturing, logistics, and construction sectors. Wearable robots and exoskeletons have been used to increase the productivity and efficiency of industrial operations while lowering worker fatigue and injury risks. Due to the growing demand for automation and robotics in the manufacturing sector, the market is anticipated to continue expanding. As businesses look to increase worker productivity and safety, wearable robots and exoskeletons are also anticipated to become more common in the logistics and construction sectors.
The rehabilitation segment is expected to have the highest CAGR during the forecast period
The rehabilitation segment is anticipated to witness the fastest CAGR growth during the forecast period. The rehabilitation sector has experienced some of the fastest growth in the market. This is brought on by an increase in both the prevalence of disabilities and the demand for medical equipment that can speed up patients' recoveries from illnesses and injuries. The rehabilitation market is expanding as a result of the availability of wearable robots and exoskeletons that can offer patients with mobility impairments the much-needed assistance they require. In the years to come, this trend is anticipated to persist.
During the forecast period, North America is anticipated to account for the largest share of the global market for wearable robots and exoskeletons, due to the rising demand for devices that can enhance patient outcomes and worker safety, the healthcare and industrial sectors have been the main drivers of growth in North America. Moreover, the growth of the market in North America has also been aided by the presence of significant manufacturers and technological advancements in the area.
Due to the growing use of these devices in the industrial and healthcare sectors in the region, Asia-Pacific is predicted to have the market for wearable robots and exoskeletons with the highest CAGR. The Asia-Pacific market is anticipated to expand as a result of the region's aging population and high prevalence of disabilities. The availability of inexpensive labor and supportive government initiatives to encourage the adoption of cutting-edge technologies are also anticipated to fuel market expansion in the area.
Key players in the market
Some of the key players in Wearable Robots And Exoskeletons market include ATOUN Inc, Bionik Laboratories Corp., B-Temia Inc., Cyberdyne Inc, Daiya Industry Co., Ltd., Ekso Bionics Holdings, Inc., Focal Meditech BV, Honda Motor Co. Ltd, Lockheed Martin Corporation, Mitsubishi Heavy Industries, Ltd., Myomo Inc., P&S Mechanics Co. Ltd., Parker Hannifin Corporation, ReWalk Robotics Ltd., Rex Bionics Pty Ltd., Sarcos Corporation, Technaid S and Wearable Robotics Srl.
In May 2024, Japanese automaker Honda Motor Co said its subsidiary Honda R&D (India) Pvt Ltd has opened a new Solution R&D center in Bengaluru, Karnataka. Honda R&D (India) is the research and development arm for Honda's motorcycles and power products in India. The new R&D Center will incorporate advanced mobility technologies into electric vehicle development more quickly. It will also work on software and connected services through 'co-creating' open innovation by adopting technologies and ideas of R&D companies.
In March 2024, Sarcos Technology and Robotics Corporation ("Sarcos") (NASDAQ: STRC and STRCW) is pleased to announce that effective today, the company has changed its name to Palladyne AI Corp. (Palladyne AI). Effective April 8, 2024, the Company's ticker symbol will change from NASDAQ: STRC to NASDAQ: PDYN. The new name reflects the company's narrowed focus on commercializing the artificial intelligence and machine learning software that it has been developing since 2020.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.